Measure: CMS147
Preventive Care and Screening: Influenza Immunization
Measure Versions
| eMeasure Code |
Measure Year |
Full Version Number |
Title |
| CMS147v13 |
2024 |
|
Preventive Care and Screening: Influenza Immunization |
| CMS147v12 |
2023 |
12 |
Preventive Care and Screening: Influenza Immunization |
| CMS147v11 |
2022 |
11.0.000 |
Preventive Care and Screening: Influenza Immunization |
| CMS147v10 |
2021 |
10.2.000 |
Preventive Care and Screening: Influenza Immunization |
| CMS147v9 |
2020 |
9.1.000 |
Preventive Care and Screening: Influenza Immunization |
| CMS147v8 |
2019 |
8.1.000 |
Preventive Care and Screening: Influenza Immunization |
| CMS147v7 |
2018 |
7.2.000 |
Preventive Care and Screening: Influenza Immunization |
| CMS147v6 |
2017 |
6.1.000 |
Preventive Care and Screening: Influenza Immunization |
Description
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
Guidance
The timeframe for the visit during the "Encounter, Performed": "Encounter-Influenza" or "Procedure, Performed": "Peritoneal Dialysis" or "Procedure, Performed": "Hemodialysis" in the Population Criteria-Denominator, refers to the influenza season defined by the measure: October through March (October 1 for the year prior to the start of the reporting period through March 31 during the reporting period). The "Encounter-Influenza" Grouping OID detailed in the data criteria section below is comprised of several individual OIDs of different encounter types. The individual OIDs are included in the value set and should be reviewed to determine that an applicable visit occurred during the timeframe for "Encounter, Performed": "Encounter-Influenza" as specified in the denominator.
To enable reporting of this measure at the close of the reporting period, this measure will only assess the influenza season that ends in March of the reporting period. The subsequent influenza season (ending March of the following year) will be measured and reported in the following year.
Due to the changing stance of the CDC/ACIP recommendations regarding the live attenuated influenza vaccine (LAIV) for a particular flu season, this measure will not include the administration of this specific formulation of the flu vaccination. Given the variance of the timeframes for the annual update cycles, program implementation, and publication of revised recommendations from the CDC/ACIP, it has been determined that the coding for this measure will specifically exclude this formulation, so as not to inappropriately include this form of the vaccine for flu seasons when CDC/ACIP explicitly advise against it. However, it is recommended that all eligible professionals or eligible clinicians to review the guidelines for each flu season to determine appropriateness of the LAIV and other formulations of the flu vaccine. Should the LAIV be recommended for administration for a particular flu season, eligible professional or clinician may consider one of the following options: 1) satisfy the numerator by reporting either previous receipt or using the CVX 88 for unspecified formulation, 2) report a denominator exception, either as a patient reason (e.g., for patient preference) or a system reason (e.g., the institution only carries LAIV).
This eCQM is a patient-based measure.
This version of the eCQM uses QDM version 5.5. Please refer to the eCQI resource center (https://ecqi.healthit.gov/qdm) for more information on the QDM.
Patient Group Definitions
| Group |
Description |
Instructions Links |
| Initial Population | All patients aged 6 months and older seen for a visit during the measurement period | Webchart Instructions |
| Denominator | Equals Initial Population and seen for a visit between October 1 and March 31 | Webchart Instructions |
| Denominator Exclusions | None | |
| Numerator | Patients who received an influenza immunization OR who reported previous receipt of an influenza immunization | Webchart Instructions |
| Numerator Exclusions | Not Applicable | Webchart Instructions |
| Denominator Exceptions | Documentation of medical reason(s) for not receiving influenza immunization (e.g., patient allergy, other medical reasons).
Documentation of patient reason(s) for not receiving influenza immunization (e.g., patient declined, other patient reasons).
Documentation of system reason(s) for not receiving influenza immunization (e.g., vaccine not available, other system reasons). | Webchart Instructions |
Details
| Full eMeasure Code |
eMeasure Identifier |
Measure Year |
Version |
NQF # |
GUID |
| CMS147v10 |
147 |
2021 |
10.2.000 |
0041e |
a244aa29-7d11-4616-888a-86e376bfcc6f |
| Steward |
Developer |
Endorsed By |
| American Medical Association (AMA) |
PCPI(R) Foundation (PCPI[R]) |
National Quality Forum |
| Scoring Method |
Measure Type |
Stratification |
Risk Adjustment |
| Proportion |
PROCESS |
None |
None |
Rate Aggregation
None
Improvement Notation
Higher score indicates better quality
Rationale
Influenza vaccination is the most effective protection against influenza virus infection (Centers for Disease Control and Prevention [CDC], 2018). Influenza may lead to serious complications including hospitalization or death (CDC, 2018). Influenza vaccine is recommended for all persons aged >=6 months who do not have contraindications to vaccination. However, data indicate that less than half of all eligible individuals receive an influenza vaccination (CDC, 2015). This measure promotes annual influenza vaccination for all persons aged >= 6 months.
Clinical Recommendation Statement
Routine annual influenza vaccination is recommended for all persons aged >= 6 months who do not have contraindications. Optimally, vaccination should occur before onset of influenza activity in the community. Although vaccination by the end of October is recommended, vaccine administered in December or later, even if influenza activity has already begun, is likely to be beneficial in the majority of influenza seasons (CDC/Advisory Committee on Immunization Practices [ACIP], 2019).
Definition
Previous Receipt - receipt of the current season's influenza immunization from another provider OR from same provider prior to the visit to which the measure is applied (typically, prior vaccination would include influenza vaccine given since August 1st)
Transmission Format
TBD
Applicable Value Sets
| Category |
Value Set |
OID |
| Allergy/Intolerance |
Egg Substance |
2.16.840.1.113883.3.526.3.1537 |
| Allergy/Intolerance |
Influenza Vaccination |
2.16.840.1.113883.3.526.3.402 |
| Allergy/Intolerance |
Influenza Vaccine |
2.16.840.1.113883.3.526.3.1254 |
| Assessment, Performed |
Previous Receipt of Influenza Vaccine |
2.16.840.1.113883.3.526.3.1185 |
| Diagnosis |
Allergy to Eggs |
2.16.840.1.113883.3.526.3.1253 |
| Diagnosis |
Allergy to Influenza Vaccine |
2.16.840.1.113883.3.526.3.1256 |
| Diagnosis |
Intolerance to Influenza Vaccine |
2.16.840.1.113883.3.526.3.1257 |
| Encounter, Performed |
Annual Wellness Visit |
2.16.840.1.113883.3.526.3.1240 |
| Encounter, Performed |
Care Services in Long-Term Residential Facility |
2.16.840.1.113883.3.464.1003.101.12.1014 |
| Encounter, Performed |
Discharge Services - Nursing Facility |
2.16.840.1.113883.3.464.1003.101.12.1013 |
| Encounter, Performed |
Encounter-Influenza |
2.16.840.1.113883.3.526.3.1252 |
| Encounter, Performed |
Home Healthcare Services |
2.16.840.1.113883.3.464.1003.101.12.1016 |
| Encounter, Performed |
Nursing Facility Visit |
2.16.840.1.113883.3.464.1003.101.12.1012 |
| Encounter, Performed |
Office Visit |
2.16.840.1.113883.3.464.1003.101.12.1001 |
| Encounter, Performed |
Outpatient Consultation |
2.16.840.1.113883.3.464.1003.101.12.1008 |
| Encounter, Performed |
Patient Provider Interaction |
2.16.840.1.113883.3.526.3.1012 |
| Encounter, Performed |
Preventive Care - Established Office Visit, 0 to 17 |
2.16.840.1.113883.3.464.1003.101.12.1024 |
| Encounter, Performed |
Preventive Care Services - Established Office Visit, 18 and Up |
2.16.840.1.113883.3.464.1003.101.12.1025 |
| Encounter, Performed |
Preventive Care Services - Group Counseling |
2.16.840.1.113883.3.464.1003.101.12.1027 |
| Encounter, Performed |
Preventive Care Services - Other |
2.16.840.1.113883.3.464.1003.101.12.1030 |
| Encounter, Performed |
Preventive Care Services-Individual Counseling |
2.16.840.1.113883.3.464.1003.101.12.1026 |
| Encounter, Performed |
Preventive Care Services-Initial Office Visit, 18 and Up |
2.16.840.1.113883.3.464.1003.101.12.1023 |
| Encounter, Performed |
Preventive Care- Initial Office Visit, 0 to 17 |
2.16.840.1.113883.3.464.1003.101.12.1022 |
| Patient Characteristic Ethnicity |
Ethnicity |
2.16.840.1.114222.4.11.837 |
| Patient Characteristic Payer |
Payer |
2.16.840.1.114222.4.11.3591 |
| Patient Characteristic Race |
Race |
2.16.840.1.114222.4.11.836 |
| Patient Characteristic Sex |
ONC Administrative Sex |
2.16.840.1.113762.1.4.1 |
| Procedure, Not Performed |
Influenza Vaccination |
2.16.840.1.113883.3.526.3.402 |
| Procedure, Performed |
Hemodialysis |
2.16.840.1.113883.3.526.3.1083 |
| Procedure, Performed |
Influenza Vaccination |
2.16.840.1.113883.3.526.3.402 |
| Procedure, Performed |
Peritoneal Dialysis |
2.16.840.1.113883.3.526.3.1084 |
References
Centers for Disease Control and Prevention. (2018, October 26). About Flu. Retrieved from
http://www.cdc.gov/flu/about/disease/index.htm
Centers for Disease Control and Prevention. (2015, September 17). Flu vaccination coverage: United States, 2014-15 influenza season. Retrieved from
http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm
Grohskopf, L.A., Alyanak, E., Broder, K. R., Walter, E.B., Fry, A. M., Jernigan, D. B. (2019). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2019-20 Influenza Season. MMWR Recommendations and Reports; 38(No. RR-3), 1-21. doi: http://dx.doi.org/10.15585/mmwr.rr6803a1
Disclaimer
The Measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications.
The Measure, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain.
Commercial uses of the Measure require a license agreement between the user and the PCPI(R) Foundation (PCPI[R]). Neither the PCPI, nor the American Medical Association (AMA), nor the former AMA-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI), nor their members shall be responsible for any use of the Measure.
The PCPI encourages use of the Measure by other health care professionals, where appropriate.
THE MEASURE AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the PCPI and its members and former members of the AMA-PCPI disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications.
CPT(R) contained in the Measure specifications is copyright 2004-2019 American Medical Association. LOINC(R) is copyright 2004-2019 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2019 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2019 World Health Organization. All Rights Reserved.
Due to technical limitations, registered trademarks are indicated by (R) or [R].
Copyright
Copyright 2020 PCPI(R) Foundation. All Rights Reserved.
Source:
https://ecqi.healthit.gov/ecqm/measures/cms147v1